
Massive Bio connects cancer patients to appropriate oncology clinical trials and accelerates enrollment for sponsors. The AI-powered platform analyzes medical records, genomic and clinical data to…

Massive Bio connects cancer patients to appropriate oncology clinical trials and accelerates enrollment for sponsors. The AI-powered platform analyzes medical records, genomic and clinical data to…
What they do: AI platform that matches cancer patients to clinical trials and provides concierge enrollment support
Founded: 2014–2015 (company sources list both years)
Headquarters: New York City
Reported patients: Tens of thousands of onboarded cancer patients (reported figures: ~60,000; another source: 160,000)
Total funding (reported): Approximately $23.8M reported across disclosed rounds
Oncology clinical-trial access and patient recruitment
2014
Hospitals and Health Care
2600000
Company reported a $2.6M financing led by Revo Capital
9000000
Company reported a $9M round to scale growth and global expansion
“Includes development finance institutions, venture investors, and philanthropic backers (examples named in disclosures: DEG, IFC, Revo Capital, Charles & Lynn Schusterman Family Philanthropies)”
| Company |
|---|
About Massive Bio Every cancer patient deserves access to treatment options. Massive Bio is an AI-powered precision medicine platform transforming how cancer patients discover and access clinical trials by eliminating the barriers of geography, financial constraints, and information asymmetry that have historically limited enrollment.
Founded in 2015 and headquartered in the US, Massive Bio is scaling its impact globally by powering operations across multiple countries and bringing innovative cancer treatment options to a rapidly growing and diverse population of patients. Through our proprietary AI platform, we connect individuals to clinical trials worldwide and partner with leading pharmaceutical companies, contract research organizations (CROs), and healthcare systems to accelerate drug development and expand equitable access to cutting-edge therapies.
The Role We are hiring a Global Enrollment Systems Lead to design and optimize the operational engine that converts AI-matched patients into randomized trial participants at scale.
This is not a coordination role.
This is a systems architecture and throughput optimization role.
You will:
You will work across internal teams (AI, clinical operations, customer success) and external stakeholders (sites, sponsors, CROs, networks) to eliminate friction and maximize conversion.
This is a high-autonomy role with direct exposure to leadership and co-founders. As volume scales, you will build and lead a team to expand operational capacity.
What You’ll Actually Do Think like an industrial engineer inside one of the most complex operational systems in healthcare.
You will:
This is a live, multi-country, multi-stakeholder system — not a theoretical exercise.
Success Metrics (You Own These) You will be accountable for measurable impact:
Enrollment speed is the product. You own it.
Who This Role Is For This role is ideal for someone who:
You might come from:
Required Experience
Strongly Preferred
Why This Role Is Different You are not inheriting a mature, slow-moving department.
You are building the enrollment operating system for a global AI-enabled oncology platform.
Every week of cycle time reduction accelerates access to life-saving therapies.
Within 12–18 months, this role is expected to evolve into a broader operational leadership position as you build and lead your own team.
If you get energy from turning complexity into scalable systems — and want your optimization work to directly impact cancer patients worldwide — this is your arena.
Powered by JazzHR
hnE2Auspy7
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
80,000+
Open Roles
4,000+
New This Week